The mechanisms linking human immunodeficiency virus replication to the progressive immunodeficiency of acquired immune deficiency syndrome are controversial, particularly the relative contribution of CD4+ T cell destruction. Here, we used the simian immunodeficiency virus (SIV) model to investigate the relationship between systemic CD4+ T cell dynamics and rapid disease progression. Of 18 rhesus macaques (RMs) infected with CCR5-tropic SIVmac239 (n = 14) or CXCR4-tropic SIVmac155T3 (n = 4), 4 of the former group manifested end-stage SIV disease by 200 d after infection. In SIVmac155T3 infections, naive CD4+ T cells were dramatically depleted, but this population was spared by SIVmac239, even in rapid progressors. In contrast, all SIVmac239-infected RMs demonstrated substantial systemic depletion of CD4+ memory T cells by day 28 after infection. Surprisingly, the extent of CD4+ memory T cell depletion was not, by itself, a strong predictor of rapid progression. However, in all RMs destined for stable infection, this depletion was countered by a striking increase in production of short-lived CD4+ memory T cells, many of which rapidly migrated to tissue. In all rapid progressors (P < 0.0001), production of these cells initiated but failed by day 42 of infection, and tissue delivery of new CD4+ memory T cells ceased. Thus, although profound depletion of tissue CD4+ memory T cells appeared to be a prerequisite for early pathogenesis, it was the inability to respond to this depletion with sustained production of tissue-homing CD4+ memory T cells that best distinguished rapid progressors, suggesting that mechanisms of the CD4+ memory T cell generation play a crucial role in maintaining immune homeostasis in stable SIV infection.
Skip Nav Destination
Article navigation
15 November 2004
Article Contents
Article|
November 15 2004
Insufficient Production and Tissue Delivery of CD4 + Memory T Cells in Rapidly Progressive Simian Immunodeficiency Virus Infection
Louis J. Picker,
Louis J. Picker
1Vaccine and Gene Therapy Institute, Department of Pathology and Department of Molecular Microbiology and Immunology, and the Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006
Search for other works by this author on:
Shoko I. Hagen,
Shoko I. Hagen
1Vaccine and Gene Therapy Institute, Department of Pathology and Department of Molecular Microbiology and Immunology, and the Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006
Search for other works by this author on:
Richard Lum,
Richard Lum
1Vaccine and Gene Therapy Institute, Department of Pathology and Department of Molecular Microbiology and Immunology, and the Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006
Search for other works by this author on:
Edward F. Reed-Inderbitzin,
Edward F. Reed-Inderbitzin
1Vaccine and Gene Therapy Institute, Department of Pathology and Department of Molecular Microbiology and Immunology, and the Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006
Search for other works by this author on:
Lyn M. Daly,
Lyn M. Daly
1Vaccine and Gene Therapy Institute, Department of Pathology and Department of Molecular Microbiology and Immunology, and the Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006
Search for other works by this author on:
Andrew W. Sylwester,
Andrew W. Sylwester
1Vaccine and Gene Therapy Institute, Department of Pathology and Department of Molecular Microbiology and Immunology, and the Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006
Search for other works by this author on:
Joshua M. Walker,
Joshua M. Walker
1Vaccine and Gene Therapy Institute, Department of Pathology and Department of Molecular Microbiology and Immunology, and the Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006
Search for other works by this author on:
Don C. Siess,
Don C. Siess
1Vaccine and Gene Therapy Institute, Department of Pathology and Department of Molecular Microbiology and Immunology, and the Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006
Search for other works by this author on:
Michael Piatak, Jr.,
Michael Piatak, Jr.
4AIDS Vaccine Program, Science Applications International Corporation Frederick, Inc., National Cancer Institute (NCI), Frederick, MD 21702
Search for other works by this author on:
Chenxi Wang,
Chenxi Wang
2Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL 35294
Search for other works by this author on:
David B. Allison,
David B. Allison
2Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL 35294
Search for other works by this author on:
Vernon C. Maino,
Vernon C. Maino
3Becton Dickinson Biosciences, San Jose, CA 95131
Search for other works by this author on:
Jeffrey D. Lifson,
Jeffrey D. Lifson
4AIDS Vaccine Program, Science Applications International Corporation Frederick, Inc., National Cancer Institute (NCI), Frederick, MD 21702
Search for other works by this author on:
Toshiaki Kodama,
Toshiaki Kodama
5Department of Molecular Genetics and Biochemistry, University of Pittsburgh, Pittsburgh, PA 15260
Search for other works by this author on:
Michael K. Axthelm
Michael K. Axthelm
1Vaccine and Gene Therapy Institute, Department of Pathology and Department of Molecular Microbiology and Immunology, and the Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006
Search for other works by this author on:
Louis J. Picker
1Vaccine and Gene Therapy Institute, Department of Pathology and Department of Molecular Microbiology and Immunology, and the Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006
Shoko I. Hagen
1Vaccine and Gene Therapy Institute, Department of Pathology and Department of Molecular Microbiology and Immunology, and the Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006
Richard Lum
1Vaccine and Gene Therapy Institute, Department of Pathology and Department of Molecular Microbiology and Immunology, and the Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006
Edward F. Reed-Inderbitzin
1Vaccine and Gene Therapy Institute, Department of Pathology and Department of Molecular Microbiology and Immunology, and the Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006
Lyn M. Daly
1Vaccine and Gene Therapy Institute, Department of Pathology and Department of Molecular Microbiology and Immunology, and the Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006
Andrew W. Sylwester
1Vaccine and Gene Therapy Institute, Department of Pathology and Department of Molecular Microbiology and Immunology, and the Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006
Joshua M. Walker
1Vaccine and Gene Therapy Institute, Department of Pathology and Department of Molecular Microbiology and Immunology, and the Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006
Don C. Siess
1Vaccine and Gene Therapy Institute, Department of Pathology and Department of Molecular Microbiology and Immunology, and the Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006
Michael Piatak, Jr.
4AIDS Vaccine Program, Science Applications International Corporation Frederick, Inc., National Cancer Institute (NCI), Frederick, MD 21702
Chenxi Wang
2Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL 35294
David B. Allison
2Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL 35294
Vernon C. Maino
3Becton Dickinson Biosciences, San Jose, CA 95131
Jeffrey D. Lifson
4AIDS Vaccine Program, Science Applications International Corporation Frederick, Inc., National Cancer Institute (NCI), Frederick, MD 21702
Toshiaki Kodama
5Department of Molecular Genetics and Biochemistry, University of Pittsburgh, Pittsburgh, PA 15260
Michael K. Axthelm
1Vaccine and Gene Therapy Institute, Department of Pathology and Department of Molecular Microbiology and Immunology, and the Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006
Address correspondence to Louis J. Picker, Vaccine and Gene Therapy Institute, Oregon Health & Science University, West Campus, 505 NW 185th Ave., Beaverton, OR 97006. Phone: (503) 418-2720; Fax: (503) 418-2719; email: [email protected]
Abbreviations used in this paper: APC, allophycocyanin; BAL, bronchoalveolar lymphocyte; BrdU, 5-bromo-2′-deoxyuridine; RhCMV, rhesus CMV; RM, rhesus macaque; SIV, simian immunodeficiency virus.
Received:
May 27 2004
Accepted:
September 23 2004
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2004
J Exp Med (2004) 200 (10): 1299–1314.
Article history
Received:
May 27 2004
Accepted:
September 23 2004
Citation
Louis J. Picker, Shoko I. Hagen, Richard Lum, Edward F. Reed-Inderbitzin, Lyn M. Daly, Andrew W. Sylwester, Joshua M. Walker, Don C. Siess, Michael Piatak, Chenxi Wang, David B. Allison, Vernon C. Maino, Jeffrey D. Lifson, Toshiaki Kodama, Michael K. Axthelm; Insufficient Production and Tissue Delivery of CD4+Memory T Cells in Rapidly Progressive Simian Immunodeficiency Virus Infection . J Exp Med 15 November 2004; 200 (10): 1299–1314. doi: https://doi.org/10.1084/jem.20041049
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement